Orforglipron In phase II, randomized, double-blind study, adults with overweight or obesity and without T2DM who took oral orforglipron (12, 24, 36, or 45 mg) daily for 36 weeks experienced a weight reduction of 9.414.7% [105]
Oral therapy with higher doses can be given initially, but in cases of manifest B12 deficiency, parenteral therapy should be preferred for faster remission and liver repletion
The angiogenic action appears tied to T4s actin-binding motif: Philp et al., FASEB J 2003 demonstrated that this seven-residue site is essential for promoting endothelial migration and vessel formation
The identified compound KL1 sensitizes intracellular bacteria to antibiotic killing by reducing the production of reactive species upon infection, presumably by targeting the EHMT2/G9a activity
There are many ways to gain B12 through meals
Fertility and Sterility , 98(3), 564-571